糖尿病患者的阿司匹林和氯吡格雷抵抗 - Suppr

Suppr

超能文献

Aspirin and clopidogrel resistance in patients with diabetes mellitus.

作者信息

Scheen André J, Legrand Delphine

出版信息

Eur Heart J. 2006 Dec;27(23):2900; author reply 2900-1. doi: 10.1093/eurheartj/ehl295. Epub 2006 Oct 2.

DOI:10.1093/eurheartj/ehl295

PMID:17015405

Abstract

摘要

相似文献

Aspirin and clopidogrel resistance in patients with diabetes mellitus.糖尿病患者的阿司匹林和氯吡格雷抵抗

Eur Heart J. 2006 Dec;27(23):2900; author reply 2900-1. doi: 10.1093/eurheartj/ehl295. Epub 2006 Oct 2.

Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus.氯吡格雷相对于阿司匹林在糖尿病患者中的增效作用。

Am J Cardiol. 2002 Sep 15;90(6):625-8. doi: 10.1016/s0002-9149(02)02567-5.

Antiplatelet therapy in diabetes: efficacy and limitations of current treatment strategies and future directions.糖尿病中的抗血小板治疗：当前治疗策略的疗效、局限性及未来方向

Diabetes Care. 2009 Apr;32(4):531-40. doi: 10.2337/dc08-2064.

Aspirin therapy in diabetes mellitus.糖尿病中的阿司匹林治疗。

Diabetologia. 1997 Jul;40(7):867.

Diabetes, vascular complications and antiplatelet therapy: open problems.糖尿病、血管并发症与抗血小板治疗：待解决的问题。

Acta Diabetol. 2009 Dec;46(4):253-61. doi: 10.1007/s00592-008-0079-y. Epub 2008 Dec 2.

Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.缓释双嘧达莫与低剂量阿司匹林固定剂量组合与氯吡格雷联合或不联合阿司匹林在2型糖尿病和短暂性脑缺血发作病史患者中的抗血小板谱：一项随机、单盲、30天试验。

Clin Ther. 2008 Feb;30(2):249-59. doi: 10.1016/j.clinthera.2008.02.006.

Aspirin in type 2 diabetes: is there any evidence base?2型糖尿病中的阿司匹林：有任何循证依据吗？

BMJ. 2008 Oct 16;337:a1902. doi: 10.1136/bmj.a1902.

Impact of adjunctive cilostazol therapy versus high maintenance dose of clopidogrel in suboptimal responders with diabetes mellitus.

Rev Esp Cardiol (Engl Ed). 2012 Jan;65(1):105-6. doi: 10.1016/j.recesp.2011.04.008. Epub 2011 Jul 23.

A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.一项随机研究评估西洛他唑对接受双联抗血小板治疗的糖尿病和冠状动脉疾病患者血小板功能谱的影响：OPTIMUS-2研究结果

Eur Heart J. 2008 Sep;29(18):2202-11. doi: 10.1093/eurheartj/ehn287. Epub 2008 Jun 21.

Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.糖尿病对阿司匹林和氯吡格雷双联抗血小板治疗后血小板反应性的影响。

Thromb Haemost. 2008 Mar;99(3):637-9. doi: 10.1160/TH07-07-0465.

引用本文的文献

The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial.恩格列净对合并2型糖尿病和冠状动脉疾病患者炎症标志物的影响：恩格列净治疗冠状动脉疾病（EMPA-CARD）随机对照试验

Diabetol Metab Syndr. 2022 Nov 17;14(1):170. doi: 10.1186/s13098-022-00951-5.

Platelet reactivity patterns in patients treated with dual antiplatelet therapy.接受双重抗血小板治疗患者的血小板反应性模式

Eur J Clin Invest. 2019 Jun;49(6):e13102. doi: 10.1111/eci.13102. Epub 2019 Mar 29.

Study of platelet aggregation in acute coronary syndrome with special reference to metabolic syndrome.急性冠状动脉综合征中血小板聚集的研究，特别涉及代谢综合征

Int J Appl Basic Med Res. 2013 Jul;3(2):117-21. doi: 10.4103/2229-516X.117086.

Assessment of platelet function by whole blood impedance aggregometry in coronary artery bypass grafting patients on acetylsalicylic acid treatment may prompt a switch to dual antiplatelet therapy.在接受乙酰水杨酸治疗的冠状动脉搭桥手术患者中，通过全血阻抗聚集法评估血小板功能可能会促使改用双联抗血小板治疗。

Heart Vessels. 2013 Jan;28(1):57-65. doi: 10.1007/s00380-011-0216-3. Epub 2011 Dec 28.

Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact?抗血小板药物“抵抗”。第2部分：抗血小板药物的实验室抵抗——事实还是假象？

Nat Rev Cardiol. 2009 May;6(5):365-73. doi: 10.1038/nrcardio.2009.13. Epub 2009 Apr 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验